Godavari Drugs Ltd Share Price Today - Godavari Drugs Ltd Stock Price Live NSE/BSE

Godavari Drugs Ltd

NSE: BSE: 530317

₹81.77

(-1.35%)

Wed, 18 Mar 2026, 01:57 pm

MTF 5xInvest in Godavari Drugs Ltd with 5x Leverage Buy with MTF

Market Cap624.2M

PE Ratio16.68

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Godavari Drugs Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
61.93
Net Profit
4.38
P/B
1.52
Sector P/E
39.71
P/E
15.03
EV/EBITDA
9.98
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
20.07
ROCE (Industry)
20.49
RONW (Industry)
17.59
ROE
10.64
ROCE
10.06
Debt/Equity
1.48
EPS (TTM)
5.78
Dividend Yield
0
Book Value
57.56
Interest Cover
2.19

Analysis

all

Pros

Godavari Drugs is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Godavari Drugs is profitable, therefore cash runway is not a concern.
Godavari Drugs is profitable, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 2.3x debt.
Godavari Drugs's cash and other short term assets cover its long term commitments.

Cons

Unable to evaluate Godavari Drugs's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Godavari Drugs's dividend against the top 25% market benchmark as the company has not reported any payouts.
Debt is not well covered by operating cash flow (15.1%, less than 20% of total debt).
The level of debt compared to net worth has increased over the past 5 years (31.5% vs 129.5% today).
Interest payments on debt are not well covered by earnings (EBIT is 2x annual interest expense, ideally 3x coverage).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	52.61	52.61	52.63	52.63	52.63
FII	0	0	0	0	0
DII	0.50	0.50	0.50	0.50	0.50
Public	46.89	46.89	46.87	46.87	46.87
Government	0	0	0	0	0

Technical Analysis

RSI

56.74

MACD

-0.54

50 DMA

86.52

200 DMA

85.03

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	123.81	103.85	90.78	83.89	70.82	63.93	43.97
Fibonacci	103.85	96.23	91.51	83.89	76.27	71.55	63.93
Camarilla	83.20	81.37	79.54	83.89	75.88	74.05	72.22

Pivots Level: Classic

+39.92

123.81

+19.96

103.85

+6.89

90.78

83.89

Pivot Point

LTP: 86.67

-13.07

70.82

-19.96

63.93

-39.92

43.97

Moving Average

SMAEMA

Period

Value

10-EMA
82.66
20-EMA
82.74
30-EMA
83.26
50-EMA
83.66
100-EMA
83.97
200-EMA
86.44

Announcement Date	Purpose	Action
21 Jan 2026	egm
14 Nov 2025	board-meetings	Quarterly Results
04 Aug 2025	agm
30 May 2024	agm
21 Jul 2023	agm
25 Apr 2022	agm
23 Jul 2021	agm

Godavari Drugs Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd

Lupin Ltd

Godavari Drugs Ltd About

Godavari Drugs engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and its intermediates through its manufacturing facility at Nanded, Maharashtra, India.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1987

Headquarters

CEO

Ghanshyam Jaju

Employees

Contact

Website

http://www.godavaridrugs.com

info@godavaridrugs.com

Phone

91-40-27849700/27844557

Location

Mayfair 1-8-303-34, Sardar Patel Road, Secunderabad, Andhra Pradesh, 500003

Year	History
1987	GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2.
1988	The company set up a project to manufacture 180 TPA of SULPHAMETHOXAZOLE.
1989	The project to manufacture SULPHAMETHOXAZOLE was fully commissioned on July 3.
1992	The company was converted into a public limited company on September 25.
2012	The Board appointed Mr. Mohit Jaju as an Additional Director effective from May 10.

Client Name	Order Side	QTY	Avg Price	Date
TRADELINK EXIM INDIA PVT LTD	Buy	39217	98.88	16 Jan 2026
MADHUSUDHAN GUNDA	Buy	40000	106.2	26 Aug 2024
MADHUSUDHAN GUNDA	Sell	33892	112	26 Aug 2024
PRASHANT SHRIMAL	Sell	41833	93.52	15 Jun 2023
MOHIT JAJU	Buy	70000	87.99	06 Jun 2023
PRASHANT SHRIMAL	Sell	155167	88	06 Jun 2023
SUSHMA KAKANI	Buy	70000	88	06 Jun 2023
YUGA STOCKS AND COMMODITIES PRIVATE LIMITED .	Buy	45000	75.78	19 Dec 2022
ARHAM SHARE PRIVATE LIMITED	Buy	40564	75.8	19 Dec 2022
ARHAM SHARE PRIVATE LIMITED	Sell	40564	74.93	19 Dec 2022

Godavari Drugs Ltd News

Godavari Drugs EGM Approves Equity Share & Warrant Issue

Godavari Drugs Limited successfully concluded its 1st EGM for FY 2025-26 on February 12, 2026, with shareholders approving two special resolutions for preferential equity shares and convertible warrants issuance.

12 Feb 2026

co actions results

Godavari Drugs Q3FY26 Results & Loan Approval

Godavari Drugs reported Q3FY26 net profit of ₹75.76 lakhs with revenue of ₹2218.43 lakhs. Board approved ₹5.50 crore working capital loan from ICICI Bank for new order execution.

11 Feb 2026

co actions results

Godavari Drugs Board Approves Preferential Issue

Godavari Drugs Limited board approves preferential issue of 23.60 lakh convertible warrants and 25.97 lakh equity shares at ₹89 each to promoters and non-promoters, subject to shareholder approval in EGM scheduled for February 12, 2026.

15 Jan 2026

co actions results

Godavari Drugs clarifies share price movement

Godavari Drugs Limited responds to BSE inquiry on share price volatility, stating no unpublished price sensitive information exists and attributing movement to market-driven demand-supply factors.

08 Jan 2026

stocks

Godavari Drugs Reports Mixed Q2 Performance with Revenue Growth but Margin Pressure

Godavari Drugs Limited reported revenue from operations of Rs 2,664.04 lakhs for the quarter ended September 30, 2025, up from Rs 2,608.79 lakhs in the same quarter last year, with net profit rising to Rs 100.07 lakhs from Rs 108.86 lakhs. The company's half-year revenue reached Rs 5,046.07 lakhs compared to Rs 5,829.54 lakhs in the previous year, while net profit for the six-month period stood at Rs 204.13 lakhs versus Rs 271.94 lakhs last year.

14 Nov 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800